Leveragen selected as a preferred service provider by Columbia University

February 14, 2018

The Columbia Precision Medicine Initiative announced the Vagelos Precision Medicine supplemental funding for mouse models, intending to support ground-breaking research in the field of precision medicine. Leveragen was selected as a preferred genetic modeling service provider along with several major vendors.